CJC-1295/Ipamorelin No DAC is a research blend containing two synthetic peptides that act through complementary receptor pathways. CJC-1295 without DAC, also known as Modified GRF (1-29), is a 29-amino-acid analogue of growth hormone–releasing hormone. Ipamorelin is a synthetic pentapeptide that acts as an agonist of the ghrelin/growth hormone secretagogue receptor.
This blend has been studied in laboratory models involving growth hormone signaling and related endocrine pathways. The no-DAC form does not contain the albumin-binding Drug Affinity Complex found in DAC-modified CJC-1295.
Structure: Two-component synthetic peptide blend
Components: CJC-1295 without DAC (Modified GRF 1-29) and Ipamorelin
CJC-1295 No DAC Structure: 29-amino-acid GHRH analogue
Ipamorelin Structure: Synthetic pentapeptide
Molecular Formula: Not applicable as a single formula; each component has a distinct molecular structure
Receptor Activity: GHRH receptor and ghrelin/growth hormone secretagogue receptor agonists
Research Use Only: Not intended for human or veterinary use.